Osteoclasts are bone-resorbing cells that differentiate from macrophage precursors in response to receptor activator of NF-KB ligand (RANKL). In vitro models of osteoclast differentiation are principally based on primary cell cuhures, which are poorly suited to molecular and transgene studies because of the limitations associated with the use of primary macrophage. RAW264.7 is a transfectable macrophage cell line with the capacity to form osteoclast-like cells. In the present study, we have identified osteoclast precursors among clones of RAW264.7 cells. RAW264.7 cell were cloned by limiting dilution and induced to osteoclast differentiation by treatment with recombinant RANKL. Individual RAW264.7 cell clones formed tartrate resistant acid phosphatase (TRAP)-positive multinuclear cells to various degrees with RANKL treatment. All clones tested expressed the RANKL receptor RANK. Each of the clones expressed the osteoclast marker genes TRAP and cathepsin-K mRNA with RANKL treatment. However, we noted that only select clones were able to form large, well-spread, TRAP-positive multinuclear cells. Clones capable of forming large TRAP-positive muhinuclear ceils also expressed ~3 integrin and calcitonin receptor mRNAs and were capable of resorbing a mineralized matrix. All clones tested activated NF-KB with RANKL treatment, cDNA expression profiling of osteoclast precursor RAW264.7 cell clones demonstrates appropriate expression of a large number of genes before and after osteoclastic differentiation. These osteoclast precursor RAW264.7 cell clones provide a valuable model for dissecting the cellular and molecular regulation of osteoclast differentiation and activation.
INTRODUCTION
Bone-resorbing osteoclasts are terminally differentiated polykaryons of the monocyte/macrophage lineage that are specialized cells responsible for physiological bone resorption as well as pathologic bone loss. Osteoclast differentiation is primarily mediated by osteoblast lineage cells and marrow stromal cells through their expression of growth factors and cytokines, including macrophage colony stimulating factor (MCSF) and receptor activator of NFKB ligand (RANKL) . RANKL acts directly on osteoclast precursors, via the receptor RANK, to induce differentiation of precursors to muhinuclear bone resorbing cells Hsu et al., 1999) . RANK is a member of the tumor necrosis factor (TNF) receptor family and shares signaling pathways common to this family of receptors. On stimulation with RANKL, RANK signals via TRAF2 and TRAF6 to activate downstream signaling pathways, including activation of the transcription factors NF-KB and Apl (fos/jun) (Wong et al., 1998; Armstrong et al., 2002; Lee et al., 2002) . RANKL/RANK interaction also initiates calcium signaling, which leads to the activation of the nuclear factor of activated T cells (NFATcl), a transcription factor crucial to osteoclast differ-1 To whom correspondence should be addressed at E-mail: kmchugh@bidmc.harvard.edu entiation (Takayanagi et al., 2002) . These transcription factors, and others, direct the expression or repression of the unique set of genes associated with osteoclast differentiation and activation. Marker genes that are up-regulated in early osteoclast differentiation include tartrate resistant acid phosphatase (TRAP) and cathepsin-K (Cath-K), whereas the integrin ~3 and the calcitonin receptor (CTR) are expressed only by ,nature osteoclasts (Hattersley and Chambers, 1989; Lee et al., 1995) .
Biochemical studies of osteoclast differentiation and function have been hindered because a tractable cell culture model of osteoclast differentiation has not been available. To address questions relating to osteoclast differentiation, earlier in vitro studies differentiated mouse osteociasts from primary monocyte/macrophage or splenocyte precursors by coculture with primary osteoblasts or stroreal cell lines (Takahashi et al., 1988; Quinn et al., 1997 Quinn et al., , 1998b . Treatment of the cocuhures with collagenase released the osteoblast/ stromal cell component, allowing the isolation of osteoclast-like cells (Shioi et al., 1994; Abu-Amer et al., 1997; Inoue et al., 2000) . Various techniques have been employed to identify the cell target in these mixed cultures, including treatment of cells before coculture and using mixed cocultures from genetically modified strains of mice (Abu-Amer et al., 2000) . These procedures fail to produce the pure populations of in vitro-generated osteoclasts that are required for biochemical and molecular analyses. With the identifi-cation of RANKL/RANK signaling as an essential requirement for osteoclast formation, primary osteoclast precursor cells (bone marrow macrophage [BMMs] , splenocytes, and peripheral blood monocytes) can now be induced to osteoclastic differentiation in vitro by culture in the presence of recombinant MCSF and RANKL (Quinn et al., 1998a) . However, difficulties are associated with the use of these primary cells including limited availability and variation in response patterns between different preparations. A crucial limitation of primary cell-derived osteoclasts and their precursors is that they are virtually untransfectable and, thus, are poorly suited for genetic manipulation and promoter studies.
The mouse macrophage cell line RAW264.7 has been identified as a transfectable RANK-expressing cell line (Hsu et al., 1999; Thompson et al., 1999) . RANKL has been shown to activate NF-KB and to induce limited osteoclastic differentiation and bone resorption in RAW264.7 cells (Hsu et al., 1999; Wei et al., 2001; Matsuo et al., 2004) . The RAW264.7 cell line is well characterized with regard to macrophage-mediated immune, metabolic, and phagocytic functions (Ralph and Nakoinz, 1977; Raschke et al., 1978; Li et al., 1996) and is increasingly used and accepted as a cellular model of osteoclast formation and function (Collin-Osdoby et al., 2003; Liu et al., 2003; Battaglino et al., 2004; Matsumoto et al., 2004; Matsuo et al., 2004; Yu et al., 2004) . This is of concern considering RAW264.7 cell-derived osteoclasts have not yet been well characterized, and RAW264.7 cells are polymoq3hic with respect to the phenotype of the individual ceils comprising this cell line (Ravasi et al., 2002) . In the cmTent studies, we observed that not all RAW264.7 cells are capable of generating osteoclasts. This finding led us to clone osteoclast precursors from the RAW264.7 cell line and to characterize the capacity to form osteoclasts. The resulting osteoclast precursor RAW264.7 cells clones provide an excellent in vitro model for dissecting the cellular and molecular regulation of osteoclast differentiation and activation.
METHODS
Cell culture and osteoclastogenesis. RAW264.7 cells (TIB 71; ATCC, Manassas, VA) were cloned in 48-well plates by limiting dilution (4 viable cells/ ml ptated at 0.25 ml per well). After 2 wk, cells from wells containing single colonies were resuspended by vigorous pipetting, expanded by culture in 6-well plates, followed by T-75 flasks; before freezing in dimethyl sulfoxide (DMSO) cell-freezing medium (Sigma, St. Louis, MO). For controls, primary mouse BMMs were prepared from 5-wk-old, male C3H/HeJ mice, as described (McHugh et at., 2001 ). All animal experiments were carried out with protocols approved by the Institutional Animal Care and Use Committee (IA-CUC) in accordance with all local, state, and federal regulations. Primary macrophages and RAW264.7 cells were cuhured in alpha minimal essential medium (c~-MEM; Mediatech, Herudon, VA) + 10% heat-inactivated fetal bovine serum (FBS) (Sigma, St. Louis, MO). Cultures of BMM and osteoclasts were supplemented with recombinant mouse macrophage colony stimulating factor (MCSF) (R&D Systems, Minneapolis, MN) at 20 ng/ml. Osteoclast-like cells were derived from primary macrophages and RAW264.7 cells by treating with 20 ng/ml recombinant mouse RANKL (R&D Systems, cat. 462-TR), and a cross-linking antibody, anti-6xhistidine (anti-6xHis), at 0.5 Ixg/ml (R&D Systems). Subsequent experiments employing non-6XHis-tagged RANKL (R&D systems, cat. 462-TEC) did not require a cross-linking antibody and gave equivalent resuhs. After 3 d of culture, 50% of the medium was changed and replenished with ct-MEM + 10% FBS and 40 ng/ml RANKL plus 0.5 ~g/ml anti-6XHis antibody in relevant cultures. MCSF was replenished in the BMM cultures. After 5 d of culture, cells were fixed in 10% formalin and stained for TRAP activity using the Leukocyte Acid Phosphatase kit (Sigma).
To assess the resorption activity of osteoclasts, RAW264.7 cell clones were plated at 1 • 104/cm 2 and cultured under differentiating conditions, as described above, on synthetic hydroxyapatite-coated slides (Osteologic; BD Biosciences, San Jose, CA). After 5 d, slides were washed with water, and mineral was visualized with yon Kossa stain (Kurihara et at., 1998) .
Qualitative reverse-transcription polymerase chain reaction assays. Total RNA was isolated with Trizol reagent, 0.5ml/well, using the manufacturer's protocol (Invitrogen, Carlsbad, CA). DNA contaminants were removed with RQ1 RNase-free DNase (Promega, Madison, WI) followed by an additional Trizol extraction. Reverse-transcription polymerase chain reaction (RT-PCR) was with the Advantage One-Step RT-PCR kit (BD Biosciences). For RANKL, TRAE and Cath-K RT-PCRs, 5ng of template RNA was reversetranscribed, and for CTR and ~a integrin RT-PCRs, 0.51xg of template RNA was transcribed. Primer sequences were as follows: TRAR 5'(AGCAGCCA AGGAGGACTACGTT)3' and 5'(TCGTTGATGTCGCACAGAGG)3', giving a 220-base pair (bp) product; Cath-K, 5'(TTAATTTGGCAGAAAAACCT)3' and 5'(AGCCGCCTCCACAGCCATAAT)3', giving a 400-bp product; RANK, 5'(CTCTATGCCCGTGTCCCCTGAAAA)3' and 5'(GGCCGCGAT GTCCCGT CCTI)3', giving a 588-bp product; ~a integrin, 5'(CCTFTGCCCAGCCTTC CA)3' and 5'(GTCCCCACAGTTACATTG)3', giving a 305-bp product; and CTR, 5'(GTCATGGTGGCTCTGGTGGTCAAC)3' and 5'(GTTGACCACCAG AGCCACCATGAC)3', giving a 270-bp product. Reverse transcription was for 1 h at 50 ~ C. PCR amplification for TRAP and Cath-K was 94 ~ C for 30 s, 56 ~ C for 30 s, and 68 ~ C for 60 s • 30 cycles. PCR for RANK was 94 ~ C for 30 s, 59 ~ C for 30 s, and 68 ~ C for 60 s • 35 cycles. CTR PCR was 94 ~ C for 30 s, 61 ~ C for 30 s, and 68 ~ C for 60 s x 40 cycles. PCR for the 13 z integrin was 94 ~ C for 30 s., 57 ~ C for 30 s, and 68 ~ C for 60 s • 40 cycles. PCR products were resolved by electrophoresis on a 2% agarose gel in Tris-phosphate-ethylenediamine-tetraacetic acid (EDTA; TPE) buffer (Maniatis et al., 1982) , stained with ethidium bromide, and photographed under ultraviolet (UV) light. PCR products were of the predicted size and sequence specificity was verified by Southern hybridization with internal probes (data not shown). For NFATcl RT-PCR, 1 tLg of total RNA, purified as described above, was reverse-transcribed in a 20-pA reaction using the SuperScript First Strand Synthesis kit (Invitrogen). For PCR amplification of cDNA, 1 txl of the RT reaction was PCR-amplified using Platinum Taq PCR Supermix (Invitrogen) according to manufactures suggested conditions. Preparation of nuclear extracts. RAW264.7 cell clones were plated in 6-well dishes at 1.5 • 105/well. After 3 d, cells were treated with RANKL at 100 ng/ml for 15 nfin, or untreated as controls. The cells were scraped in cold phosphate-buffered saline suspensions, collected, and centrifuged at 16,000 • g in an eppendorf microcentrifuge. Cell pellets were resuspended in 250 txl hypotonic lysis buffer (10 mM N-2-hydroxyethylpiperazine-N'-2-ethane-sulfonic acid-potassium hydroxide [HEPES-KOH], pH 7.9; 10 mM potassium chloride [KC1]; 1.5 mM magnesium chloride [MgC1]; 10 t~l/ml protease-inhibitor cocktail (Sigma cat. P-8340)) and allowed to swell on ice for 15 min. Cells were gently lysed by the addition of 16 txl of 10% NP-40 and incubated on ice for 10 rain. After a 30-s centrifugation at 16,000 • g, the supernatant was removed, and the nuclei were resuspended in 25 Ixl of nuclear extraction buffer (20 mM HEPES-KOH, pH7.9; 420 mM sodium chloride [NaC1]; 1.2 mM MgC1; 0.2 mM EDTA; 20% glycerol; 10 g~l/ml protease-inhibitor cocktail), and incubated on ice for 20 rain. Nuclear debris was cleared by centrifugation at 16,000 x g for 4 min at 4 ~ C. Nuclearextract supernatants were snap-frozen and stored at -80 ~ C.
Electrophoretic mobility shift assays. Double-stranded NF-KB consensus oligonucleotides, 5'(AGTTGAGGGGACTTrCCC AGGC)3' (Santa Cruz), were end-labeled with gamma-32 Phosphate Adenosine Triphosphate (PerkinElmer) and polynucleotide kinase (New England Biolabs, Beverly, MA) to a specific activity of 3.5 • 105 cpm/ng for electrophoretic mobility shift assays (EMSA). Binding reactions were prepared with 0.2 td of nuclear extract, 1 txg poly(deoxyinosine/deoxycytidine) (Amersham Biosciences, Waukesha, WI) in 10 mM Tris-hydrugen chloride (HC1; pH 7.5), 100 mM NaC1, 1 mM EDTA, 10% glycerol, 1 mM dithiothreitol (DTI), and 3 • 104 cpm of oligonucleotide probe. After a 30 min incubation on ice, complexes were resolved on precast, 5% polyacrylamide gels (BioRad, Hercules, CA) in 1• Tris-borate-EDTA (TBE) (Maniatis et at., 1982) . Gels were dried and autoradiographed for 24 h before development.
cDNA array expression profiling. RAW264.7 clones C3, C6, and Cll and primary BMMs were grown and induced to osteoclastic differentiation for 5 d as described above. Total RNA was purified from cells with Trizol (Invitrogen, Carlsbad, CA) as described above. DNA was removed fi~om RNA preparations by treatment with RQ1 RNase-free DNase (Promega), and RNA was repurified by Trizol extraction. Total RNA was reverse-transcribed using Moloney inurine leukemia virus reverse transcriptase (MMLV-RT) and prim-FIG. 1. Osteoclast formation in RAW264.7 cell clones. RAW264.7 cell clones were plated in 6-well dishes at 1 x 105 cells/well and were grown for 5 d with receptor activator of NF-KB (RANKL) (20 ng/ml) or without (control). Cells were fixed and stained for tartrate resistant acid phosphatase (TRAP) activity. Clones displaying a representative range of nmrphologies are shown (original magnification • ers specific for the 1200 genes on the mouse 1.2 Atlas eDNA array (Cloneteeh) using alpha-33 Phosphate deoxycytidine triphosphate (PerkinElmer) and the manufacturer's specified conditions. Probes were hybridized to membranes overnight at 71 ~ C and washed with a final wash of 0.1• standard saline citrate (SSC), 0.5% sodium dodecyl sulfate (SDS), at 71 ~ C for 30 min. Autoradiographic exposures were 3 d or 10 d. Autoradiographs were scanned, and the data were analyzed using the Atlas Image software (Clonetech). Global normalization was used, which normalizes based on the signal strength of all genes expressed. For graphical analysis, results for RAW264.7 cell clones C3, C6, and C11 (with or without RANKL treatment) were averaged, whereas duplicates of primary BMMs (with or without RANKL treatment) results were averaged. Data were plotted on x-y seatterplot, least-squares regression lines drawn, and Pearson correlation coefficient of the least-squares regression lines (R 2 values) calculated using Microsoft Excel 2000 software.
RESULTS
Osteoclast-like cell formation by RAW264.7 cell clones. When RAW264.7 cells were plated at low cell density and treated with RANKL, not all individual eolonies gave rise to TRAP-positive multinuclear cells (not shown). This result suggested the possible existence of clonal heterogeneity among RAW264.7 cells and prompted us to isolate clonal populations with osteoclastogenic capacity. We, therefore, eloned RAW264.7 cells by limited dilution cloning. Clones were expanded, and at confluence, stoeks were frozen in liquid nitrogen. Twelve randomly selected clones were grown out and replated at 5 x 10 ~ cells per well in six-well plates (C1-C12). Cultures were induced to differentiate into osteoclasts by treatment with 20 ng/ml RANKL for 5 d. Cultures were then fixed and stained for TRAP activity. Untreated cultures served as controls. We observed clear differences in the capacity of individual clones to form osteoclast-like cells, as shown in Fig. 1 for representative clones C1, C5, and C6. Clones C1 and C7 formed few TRAP-positive cells, whereas C5, C8, C9, and C12 formed mononuclear TRAP-positive cells or TRAP-positive muhinuelear cells that did not spread. Clones C2, C3, C4, C6, C10, and C l l formed well-spread TRAPpositive multinuclear cells. Cultures with clones C3, C6, and C l l resulted in greater than 99% TRAP-positive multinuclear cell formation. Clones C3, C6, and C l l , which formed TRAP positive multinuclear cells that were well-spread, were found in other studies to be transfectable (Crotti et al., 2006) and stable in osteoclastforming potential over several passages (tested up to 10 passages).
Osteoclast marker gene expression by RAW264.7 cell clones.
To determine the pattern of osteoclast gene expression in the RAW264.7 cell clones, we used qualitative RT-PCR to assess mRNA expression of a panel of osteoclast marker genes. RT-PCR targets included: RANK, TRAP, Cath-K, [33 integrin, and CTR. RNA from primary BMMs and osteoclasts derived from BMMs were amplified as controls. Each of the clones assessed, as well as the control BMM cells, qualitatively expressed RANK (Fig. 2) . RAW264.7 clones C1-C12 also expressed TRAP when treated with RANKL, as did the osteoclasts derived from primary macrophages. Cath-K was induced in all clones, with clones C2, C10, and C l l showing some constitutive Cath-K expression. Clones C2, C3, C4, C6, C10, C l l , and C12 expressed CTR and the [33 integrin when treated with RANKL. Notably, only the clones able to express [33 integrin on RANKL-induction were capable of CTR expression. Conversely, only CTR-inducible clones expressed [33 integrin with RANKL treatment (clones C2, C3, C4, C6, C10, C l l , and C12). Mineralized matrix resorption by osteoclasts from RAW264. 7 cell clones. To determine whether the osteoclasts derived from RAW264.7 clones were functional, we tested the clones for the ability to resorb synthetic hydroxyapatite films. Cells were plated on commercially available calcium phosphate matrices and induced to differentiate by treatment with RANKL, as in the previous experiments. The clones expressing the [53 integrin and CTR ( Fig. 2; clones C2, C3, C4, C6, C10, and C l l ) were eapable of resorption of mineralized matrix, as shown in Fig. 3 
FIG. 4.
Receptor activator of NF-KB (RANKL) in RAW264.7 cell clones. Electrophoretic mobility shift assay (EMSA) analysis of nuclear extracts from clones C1-C12 without (-) or with (+) RANKL treatment (100 ng/ml for 15 rain). Equal volumes of nuclear extract from treated and control samples were incubated with a radiolabeled NF-KB oligonucleotide probe for 30 min on ice. Bound complexes were separated by electrophoresis on 5% polyacrylamide in 1 • Tris-borate-ethylenediamine-tetraacetic acid (TBE). The arrow indicates the position of the NF-KB containing complex. All clones are capable of RANKL-dependent NF-KB activation.
RANK signaling, we assayed NF-KB activation in response to RANKL by EMSA. Nuclear extracts were prepared from RAW264.7 cell clones treated for 15 rain with recombinant RANKL (100 ng/ ml). This treatment regime has been shown by others to activate NF-KB in primary macrophage cells and RAW264.7 cells (Wei et al., 2001; Zhang et al., 2001) . Equal volumes of nuclear extracts from each clone, untreated and RANKL-treated, were assayed by EMSA with a labeled NF-KB consensus oligonucleotide probe. This NF-KB consensus probe has been determined by us (data not shown), and others (Wei et al., 2001) , to bind NF-KB induced by RANKL in both RAW264.7 cells and primary BMMs. Specificity of binding was demonstrated by competition with an unlabeled homologous probe and by the lack of competition with the unlabeled mutated sequences (results not shown). Additionally, identity of the protein moiety was confirmed by reaction with NF-KB p50 antiserum, producing a supershift of the retarded band (Wei et al., 2001 ). EMSA analysis indicated that all clones qualitatively respond to RANKL treatment by activation of NF-KB, as shown in Fig. 4 . The clones differed in basal, unstimulated, NF-KB-binding activity; howevel, these differences did not con'elate with the ability of each clone to induce expression of osteoclast marker genes or to form TRAP-positive, mineralized-matrix resorbing multiuuclear cells.
FIG. 5(A)
. Gene expression in primary cells versus RAW267.4 cell clones. Dense arrays were hybridized with cDNA probes from RNAs of RAW264.7 clones and mouse primrose bone marrow macrophages (BMMs). Autoradiographs were scanned and relative gene expression levels were determined, The relative expression levels from three RAW264.7 clones (123, C6, and CI1) were averaged. The primary macrophage and RAW cell genes with relative expression levels above 100 were plotted (approximately 712 genes). The circled point corresponds to c-myc. Fig. 5(B) . cDNA probes from primary osteoclasts and RAW264.7 cell-derived osteoelasts. Arrays were hybridized and analyzed as in 5(A), The relative expression levels from 3 clones (C3, C6, and CI1) were averaged, and the primary osteoclast and RAW264.7 osteoclast genes with relative expression levels above 100 were plotted (approximately 405 genes). To compare a broader range of phenotypic markers between the RAW264.7 cell clones, the osteoclasts formed from them, and the primary macrophage and osteoclasts, we profiled mRNA steady-state expression levels by cDNA array hybridization. Gene expression profiles for untreated RAW264.7 cells were compared with those of primary macrophages, and expression profiles for RAW264.7 clone-derived osteoclasts were compared with that of primary mouse marrow-derived osteoclasts. Dense cDNA array blots containing over 1200 genes were hybridized with cDNA probes from RNA of RAW264.7 cell clones and mouse primary BMMs. After overnight hybridization, blots were washed and exposed to X-ray film. Autoradiographs were scanned, and the relalive expression levels of 1187 genes were determined. The relative expression levels from 3 of the osteoclast precursor RAW264.7 clones ((23, C6, and CII) were averaged, and expression levels from duplicate primary cell experiments were averaged. Primary macrophage and RAW264.7 cell genes with relative expression levels above 100 were plotted (approximately 710 genes). As shown by x-y scatterplot in Fig. 5A , we find that untreated osteoelastogenic RAW26r cell clones, compared with primary BMMs, express largely the same complement of genes at approximately the same levels over 3 orders of magnitude. We calculated R 2 values (Pearson correlation coefficients) to quantify the similarity of the data around the least-squares regression line. The R 2 value for pair-wise comparison of primary BMMs and RAW264.7 cell clones is R 2 = 0.7953. This value is similar to those reported for same tissue comparisons and for comparison of the same cell line analyzed at different times using cDNA array profiling (Rhee et al., 1999; SmidKoopnmn et al., 2000) . The R e value of 0.7953 is much better than concordance values reported for similar cell lines and dissimilar tissues (R 2 values of 0.2 to 0.5) (Smid-Koopman et al., 2000) , A single outlier identified in this experiment, the c-myc gene, is highly expressed in RAW264.7 cells but not in the primary BMMs. To compare osteoclastic gene expression in primary osteoelasts versus RAW264.7 cell-derived osteoclasts, dense cDNA arrays were hybridized and analyzed as described above, cDNA probes were transcribed from total RNA purified from primary osteoclasts and RAW264.7-derived osteoclasts. The relative expression levels from three clones were averaged for RAW264.7-derived osteoclasts (C3, C6, and Cll). Primary osteoclast and RAW264.7 osteoclast genes with relative expression levels above 100 were plotted in an x-y scatterplot (approximately 405 genes). We find that RAW264.7 celtderived osteoclasts also express largely the same complement of genes as primary osteoclasts and at similar levels (Fig. 5B) . The correlation coefficient for the RAW264.7 clone osteoclast versus osteoclasts derived from primary BMMs is R 2 = 0.7599. Again, this is a good correlation between a cell line and primary cells using cDNA expression profiling, c-myc was induced in primary macrophage cells by RANKL treatment and is expressed at equal levels of RAW264.7 cell osteoclasts as in osteoclasts from primary BMMs.
D I S C U S S I O N
Using cell cloning, we have demonstrated significant polymorphism within the parental RAW264.7 cell line, especially with regard to osteoclast-forming potential. We found that, with RANKL treatment, all of the RAW264.7 ceil clones tested were capable of expressing the osteoclast markers, TRAE and the acid protease, Cath-K. A fraction of the clones go on to coordinately express both the [33 integrin and CTR mRNA, which are late markers of authentic, committed osteoclasts (Hattersley and Chambers, 1989; Lee et al., 1995) . Importantly, we demonstrate that most of the RAW264.7 cell clones expressing the [33 integrin and CTR were capable of resorption of mineralized matrix. We conclude that many of the parental RAW264.7 cells are blocked in the early stage of osteoclast differentiation. This conclusion explains the generally accepted observation that the parental RAW264.7 cell line exhibits a limited capacity to form osteoclasts.
Previous studies have gone to great lengths to isolate pure populations of osteoelasts from RAW264.7 cells. Methods have included lifting differentiated cells and sucrose-gradient centrifugation (Collin-Osdoby et al., 2003) . The RAW264,7 cell clones C3, C6, and C l l , isolated in this study, can essentially be considered osteoclast precursors because RANKL treatment was able to induce osteoclast gene expression and osteoclast cell morphology, along with the functional ability to resorb mineralized matrix, Our osteoclast precursor RAW264.7 cell clones produced nearly 100% TRAP-positive, multinuclear-matrix resorbing cells when treated with RANKL, making them a valuable tool for the study of osteoclast biochemistry and molecular biology. Our results also indicate that caution is required when interpreting experiments where RAW264.7 cell stable transfectants are cloned and then assayed for osteoclast formation or function. Caution is particularly warranted in the case of transgenes that are purported to inhibit osteoclast formation or function because nonosteoclast-forming cells are present at a high frequency in the parental RAW264.7 cell line and can easily be inadvertently isolated through cloning.
The interaction of RANKL with its receptor RANK is crucial to osteoclast differentiation and activation. Mice with a defect in the expression of RANKL or RANK are incapable of osteoclast differentiation and have an osteopetrotic phenotype (Kong et al., 1999; Li et al., 2000) . We, therefore, assessed whether the RAW264.7 clones that were incapable of osteoclast differentiation lack expression of the RANKL-receptor, RANK. We found that this was not the case and show that each of the clones tested express RANK mRNA. In addition, all RAW264.7 clones tested must express the RANK protein because they are all capable of responding to RANKL with TRAP and Cath-K mRNA expression. Furthermore, all clones respond to RANKL treatment with NF-KB activation and, therefore, must express the RANK receptor. These results do not rule out differences in the absolute amount of RANK expressed by individual clones because our RT-PCR assays are qualitative. To further characterize the osteoclast precursor RAW264.7 cell clones and to determine whether they are a valid cell line for the investigation of osteoclast differentiation and gene expression, we compared the cDNA expression profiles with that of primary BMMs and osteoclasts derived from them. Using expression profiling of osteoclast precursor RAW264.7 cell clones, we demonstrate that a broad range of genes are appropriately expressed in RAW264.7 cell macrophage and osteoclasts as compared with primary BMMs and osteoclasts. These results validate the osteoclast precursor RAW264.7 cell clones as an appropriate cell model for studying osteoclast transcription. A single gene of the 1200 assayed, the c-myc gene, was found to have inappropriately high expression in RAW264.7 cell macrophages. We found, howevel, that c-myc, which has been implicated in osteoclast differentiation and gene expression (Battaglino et al., 2002) , is induced in primary macrophages by RANKL to levels similar to in unstimulated RAW264.7 cells.
In conclusion, RAW264.7 is an immortal and transfectable cell line, and the clones that exhibit phenotypic and genetic patterns of RANKL-indueed osteoclast formation retain these properties. These clones are osteoclast precursors and provide a unique model for dissecting the cellular and molecular regulation of osteoclast differentiation and activation.
